Page 12 - Q2 Results

Interarch Building spurts 19% on heavy volumes; stock hits all-time high

Backed by a robust order book and strong project pipeline, Interarch Building management is confident of sustaining this growth in the second half of the year.

Paytm hits highest level since December 2021; zooms 107% from March low

Paytm Share Price Today: The stock price of fintech company Patym was trading at its highest level since December 2021.

KP Energy Q2 results: Net profit rises 44% to ₹36 cr on high revenues

KP Energy on Friday posted 44 per cent growth in its net profit to Rs 35.95 crore in September quarter compared to a year ago mainly on the back of higher revenues. "The company has recorded its highest-ever Q2 Profit After Tax (PAT) on a consolidated basis for Q2FY26 at Rs 35.94 crore in comparison to that for Q2FY25 at Rs 24.94 crore representing a growth of 44 per cent," said a regulatory filing. The company has reported a total revenue of Rs 303.47 crore in Q2FY26 reflecting a significant growth of about 50 per cent to Rs 202 crore in Q2FY25. This also marks the highest ever total revenue achieved in any second quarter, it stated. The reported quarterly basic EPS of the Company has increased from Rs 3.74 in Q2FY25 to Rs 5.36 in Q2FY26 representing an increase of about 43 per cent. The board also approved and declared second Interim Dividend at 5 per cent i.e. 25 paise per equity share having face value of Rs 5/- each of the company, for the financial year 2025-26. The Record

L&T Finance rallies 9% in weak market; why NBFC stock hit new high?

Thus far in the calendar year 2025, the stock price of L&T Finance has zoomed 122 per cent, as compared to 5.5 per cent rise in the BSE Sensex.

Cummins India share hits all-time high as Q2 profit zooms 42% YoY; details

Cummins India remains cautiously optimistic about its growth outlook across domestic and international markets, supported by a diversified portfolio aligned with evolving emission norms.

Aster DM Healthcare Q2 results: Net profit rises 13% Y-o-Y at ₹110 cr

Aster DM Healthcare reported 13 per cent year on year increase in its consolidated net profit at Rs 110 crore for the second quarter ended September 30, as per a statement. The healthcare firm reported net profit of Rs 97 crore for the July-September period of last fiscal. Revenue increased to Rs 1,197 crore for the September quarter as against Rs 1.086 crore in the year-ago period, Aster DM Healthcare said in a regulatory filing. Azad Moopen, Founder and Chairman, Aster DM Healthcare, said the company delivered a steady performance in the second quarter despite lower incidence of seasonal illnesses. "We have made progress on the merger with Quality Care India Ltd. with stock exchange no-objection letters now received. The combined platform will create one of India's most integrated and scalable healthcare networks, with complementary cluster strengths and enhanced clinical depth," he added. Shares of the company on Friday were trading 0.25 per cent down at Rs 685.55 apiece on BSE

Infosys fixes November 14 as record date for ₹18,000-crore buyback; details

Infosys share price on November 7, 2025: At 9:50 AM, the scrip was down 0.74 per cent at ₹1,455.35, while the BSE Sensex was trading 0.6 per cent lower at 82,809.14.

Smartworks Q2 results: Loss narrows to ₹3 cr, revenue rises 22% to ₹441 cr

Smartworks Coworking Spaces Ltd has narrowed its consolidated net loss to Rs 3.13 crore in the second quarter of this fiscal on higher expenses. Its net loss stood at Rs 15.82 crore in the year-ago period. Total income grew 22 per cent to Rs 441.06 crore in July-September quarter of this fiscal from Rs 360.84 crore in the corresponding period of the preceding year, according to a regulatory filing on Thursday. Neetish Sarda, Founder & Managing Director, Smartworks, said, "Our Q2 performance reflects the strength and scalability of our managed campus model. With double-digit revenue growth, expanding margins, and a negative net-debt position, Smartworks continues to deliver profitable growth at scale." Smartworks takes office spaces on rent from real estate companies to set up large campuses, which are being sub-leased to domestic and foreign companies. It has a presence across 14 cities in India and Singapore. It manages 12.7 million sq ft with 235,000+ seats as on September 30,

Amber shares tank 14% on weak Q2 results; should you buy, hold or sell?

Amber Enterprises Q2 earnings: The room air condition (RAC) industry got impacted by non-conducive weather and deferment of purchase in between announcement & implementation of GST rate reduction.

Zydus Life Q2: Solid beat on bottom line, analysts mixed on growth outlook

Zydus Life Q2 results review: Foreign brokerage Nomura said Zydus Life delivered results above estimates, led by a stronger-than-expected performance in India.

Q2 results today: Bajaj Auto, Nykaa, Hindalco among 203 firms on Nov 7

Q2FY26 company results: AstraZeneca Pharma, Spicejet, JSW Cement, Borosil, KPI Green Energy, Petronet LNG and are also to release their July-September earnings reports today

Stocks to Watch today, Nov 7: Bharti Airtel, LIC, Lupin, Bajaj Housing

Stocks to Watch today, November 7, 2025: From Bharti Airtel, LIC, Bajaj Housing Finance, Lupin, here is a list of stocks that will be in focus today

Bajaj Auto Q2 Preview: Profit, revenue to rev up on premium, export push

Brokerages expect Bajaj Auto to post healthy Y-o-Y growth in Q2, driven by higher volumes, improved product mix with a greater share of premium bikes & 3-wheelers, & favourable currency movement.

LIC Q2 profit surges 32% to ₹10,053 cr, net premium income up 5.5%

LIC's profit rose 32% YoY on stronger core operations and investment income, while CEO R Doraiswamy said GST rationalisation will drive business growth and expense optimisation

Apollo Hospitals PAT up 26% in Q2; eyes HealthCo breakeven within 2 qtrs

Strong revenue growth and specialty performance boost Apollo Hospitals' Q2 earnings, even as HealthCo narrows losses by half and targets breakeven in the next two quarters

P&G Hygiene and Health Care net profit marginally down in Q2 FY26

The FMCG firm reported a 1% drop in net profit to Rs 209.86 crore for Q2 FY26, even as revenue rose 1.32% year-on-year to Rs 1,150.17 crore amid a dynamic market environment

Innovative portfolio likely to maintain growth momentum for Sun Pharma

Specialty portfolio powers Q2; Ilumya, Leqselvi, Unloxcyt to anchor next phase

Mankind Pharma Q2 PAT drops 21% on high finance costs; revenue up 20%

Mankind Pharma's Q2 FY26 profit fell to Rs 520 crore on higher finance and input costs, even as strong domestic and export growth lifted revenue by over 20%.

Lupin Q2 PAT rises 73% on strong growth across key global markets

Lupin's consolidated profit rose 73% YoY to Rs 1,478 crore in Q2 FY26, led by robust sales in India and the US and higher margins from an improved product mix

Apollo Hospitals Q2 results: Profit rises 26% to ₹477 cr, misses estimates

Medical admissions fell, compared to the same year-ago quarter that had a higher incidence of seasonal medical admissions, the company said in a statement of Thursday